Real World Evidence (RWE) has long been heralded as a “game changer” for the life sciences industry. Real World Evidence is the term used to describe research findings that use data that is gathered outside of standard clinical trials. This informative whitepaper highlights the growth, importance, and benefits of Real World Evidence data to the pharma industry. Does it address the questions such as: Why Real-World Evidence (RWE) is an important driver of decision-making in healthcare? How does Real World Evidence analytics accelerate the Improved patient Journey and decision making?